The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Elimination of tuberculosis (TB) requires the management of latent tuberculosis infection (LTBI) in key populations. Thus, people with LTBI need to be diagnosed and treated with appropriate regimens. It is unknown how different screening and treatment strategies of key populations affect TB transmission and progress toward elimination.
The elimination of tuberculosis (TB) in Europe will require the management of latent tuberculosis infection (LTBI) in key populations. Management of LTBI requires the identification and adequate treatment of infected people. It is currently unknown how screening and treatment of key populations should be best organised to have the highest impact with the available resources.
The Annual TB Surveillance and Monitoring report presents the key figures and trends and provides an overview of the TB situation in the EU/EEA and the WHO European Region.